Recent developments in the genomics and proteomics fields have resulted in the discovery of large numbers of targets for drug development. There has been renewed interest in using peptides as primary lead compounds and modulators of these new targets. Advancements in solid phase technologies, automation, parallel synthesis, and expressing peptides by phage display have significantly increased the number of peptides being studied as potential drug candidates. They are also useful as diagnostic reagents or as starting points for mimetic and small molecule drug design.
Senn Chemicals has developed and perfected novel solid phase and solution phase technologies that allow us producing many peptide related products without the necessity of chromatographic purifications leading to significant cost savings to our clients’ projects.
Our long-standing experience in the areas of non-natural amino acids, chiral organic and carbohydrate chemistries enables Senn to meet our clients’ needs for peptidomimetics, lipopeptides, glycopeptides and well-defined polyamino acids and peptide polymers.
Senn has gained clear leadership role by running hundreds of successful manufacturing campaigns of various peptide related products in scales of up to 250kg per single batch.
ONLINE CATALOG 
